dataset

Overall survival by initial treatment modality (transarterial chemoembolization vs. sorafenib) according to pre-defined subgroups.

Authors
Publication date
7 March 2019
Publisher
Doi

    Abstract

    Overall survival by initial treatment modality (transarterial chemoembolization vs. sorafenib) according to pre-defined subgroups.</p

      Similar works

      Full text

      thumbnail-image

      Available Versions

      The Francis Crick Institute

      redirect
      oaioai:figshare.com:article/78162...
      Last time updated on 30/05/2019